2m 2m 2m 2m 2m 2m 2m
Neurocrine Biosc (NBIX)
NASDAQ
$155.28+$2.71 (+1.78%)
Price as of Aug 21, 2026 7:47 PM EDT- $15.5BMarket Cap
- 12.66%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Neurocrine Biosc (NBIX)
$155.28+$2.71 (+1.78%)
Earnings Score
Valuation | NBIX | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 1 | ||
Growth | 1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | NBIX | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 12.82% | ||
12-Month Momentum | 28.73% | ||
3-Month Risk Adjusted Momentum | 98.50% | ||
12-Month Risk Adjusted Momentum | 93.56% |
True Yield
Valuation | NBIX | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 0.39% | ||
Net Debt Paydown Yield | 1.01% |
Financial Health Score
Valuation | NBIX | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 10 |